Insider · CIK 0002039078

Paravasthu Mukund

Reports to the SEC for 1 company · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0002039078

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-05	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−43.2K sh	$13.77	−$596K	72,832
2026-03-04	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−5,377 sh	$13.31	−$71.5K	116,078
2026-03-03	NVCRNovoCure LtdA Award	Chief Operating Officer	AAward	+45.1K sh	—	—	121,455
2026-03-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+7,518 sh	—	—	7,518
2026-03-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+58.5K sh	—	—	66,006
2026-03-02	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−408 sh	$13.49	−$5,505.144	76,343
2026-02-27	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−1,555 sh	$13.66	−$21.2K	76,751
2026-01-11	NVCRNovoCure LtdF Tax Payment	Chief Operating Officer	FTax Payment	−2,133 sh	$14.35	−$30.6K	78,306
2025-11-04	NVCRNovoCure LtdF Tax Payment	Chief Operating Officer	FTax Payment	−2,949 sh	$12.23	−$36.1K	80,439
2025-11-01	NVCRNovoCure LtdF Tax Payment	Chief Operating Officer	FTax Payment	−168 sh	$12.81	−$2,152.08	83,388
2025-05-03	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−592 sh	$17.91	−$10.6K	83,556
2025-03-04	NVCRNovoCure LtdA Award	Chief Operating Officer	AAward	+55K sh	$18.19	+$1M	84,148
2025-03-04	NVCRNovoCure Ltd · Stock Options (Right to buy)A Award	Chief Operating Officer	AAward	+81.5K sh	$18.19	+$1.48M	81,499
2025-03-03	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−250 sh	$18.54	−$4,634.075	29,173
2025-02-28	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−368 sh	$18.28	−$6,728.622	29,423
2025-02-28	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−368 sh	$18.28	−$6,728.622	29,423
2025-02-27	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−1,379 sh	$19.92	−$27.5K	30,058
2025-02-27	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−267 sh	$20.55	−$5,486.583	29,791
2025-02-27	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−1,379 sh	$19.92	−$27.5K	30,058
2025-02-27	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−267 sh	$20.55	−$5,486.583	29,791
2025-01-11	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−2,160 sh	$26.81	−$57.9K	31,437
2024-11-04	NVCRNovoCure LtdA Award	Chief Operating Officer	AAward	+30.1K sh	—	—	33,597
2024-11-04	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+45.6K sh	$16.59	+$757K	45,620
2024-11-02	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−44 sh	$16.69	−$734.175	3,459
2024-11-01	NVCRNovoCure LtdS Sale	Chief Operating Officer	SSale	−160 sh	$15.88	−$2,540.416	3,503

Recent filings

Accepted (ET)
Mar 54
Paravasthu Mukund0002039078-26-000005
SEC(opens sec.gov)
Mar 34
Paravasthu Mukund0002039078-26-000004
SEC(opens sec.gov)
Jan 124
Paravasthu Mukund0002039078-26-000002
SEC(opens sec.gov)
Nov 44
Paravasthu Mukund0002039078-25-000004
SEC(opens sec.gov)
May 54
Paravasthu Mukund0001562180-25-003589
SEC(opens sec.gov)
Mar 64
Paravasthu Mukund0001562180-25-002157
SEC(opens sec.gov)
Mar 44
Paravasthu Mukund0001562180-25-001974
SEC(opens sec.gov)
Mar 34/A
Paravasthu Mukund0001562180-25-001912
SEC(opens sec.gov)
Mar 34
Paravasthu Mukund0001562180-25-001831
SEC(opens sec.gov)

Companies

NovoCure LtdChief Operating OfficerNVCR

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087